Top

Global Hodgkins Lymphoma Therapeutics Market 2014-2018

Category : Healthcare  | Published Date : Aug-2014 | Pages : 79
enquire GET DISCOUNT

About Hodgkin's Lymphoma
Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing the condition is increased if a person suffers from a medical condition that weakens the immune system. In HL, cells in the lymphatic system grow unusually and may spread beyond the lymphatic system. The infection-fighting properties of the lymphocytes are lost, making the person more susceptible to infection. The main treatments used are chemotherapy, followed by radiotherapy or chemotherapy alone. Generally surgery is not used as a treatment for the condition. 
TechNavio's analysts forecast the Global Hodgkin's Lymphoma Therapeutics market will grow at a CAGR of 6.84 percent over the period 2013-2018.
Covered in this Report
The Global Hodgkin's Lymphoma Therapeutics market can be divided into eight segments: Alkylating Antineoplastic Agents, Antibiotic Antineoplastic Agents, Antineoplastics Vinca Alkaloid Agents, Podophyllotoxin Derivative Antineoplastic Agents, Antimetabolite Antineoplastic Agents, Anthracycline Antineoplastic Agents, Antimicrotubular Antineoplastics, and Corticosteroids. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of HL that are available in the market.
TechNavio's report, the Global Hodgkin's Lymphoma Therapeutics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Hodgkin's Lymphoma Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas 
• APAC
• EMEA        
Key Vendors
• Bristol Myers Squibb Co.
• F. Hoffmann-La Roche Ltd.
• Merck & Co. Inc.
• Pfizer Inc.
Other Prominent Vendors
 
• 4SC AG
• Actinium Pharmaceuticals Inc.
• Aeterna Zentaris Inc.
• Affimed Therapeutics AG
• Hospira Inc.
• Incyte Corp.
• Novartis AG
• Philogen S.p.A.
• Seattle Genetics Inc.
• Sigma-Tau Pharmaceuticals Inc.
• Stemline Therapeutics Inc.
• Teva Pharmaceutical Industries Ltd.
Key Market Driver
• Improved Diagnostic Techniques.
• For a full, detailed list, view our report.
Key Market Challenge
• High Cost.
• For a full, detailed list, view our report.
Key Market Trend
• Increase in Awareness of HL.
• For a full, detailed list, view our report.
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

 

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

03.2.1 Product Profiles

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

07. WHO Classification of Hodgkin's lymphoma

08. Stages of Hodgkin's Lymphoma

09. Chemotherapy Options for Hodgkin’s Lymphoma

09.1 Five Forces Analysis

10. Market Segmentation by Drug Class

11. Geographical Segmentation

12. Buying Criteria

13. Rate of Incidence and Prevalence

13.1.1 US

13.1.2 UK

14. Pipeline Snapshot

15. Market Growth Drivers

16. Drivers and their Impact

17. Market Challenges

18. Impact of Drivers and Challenges

19. Market Trends

20. Trends and their Impact

21. Vendor Landscape

21.1 Competitive Scenario

21.1.1 Key News

21.1.2 Mergers and Acquisitions

21.2 Market Share Analysis 2013

21.3 Other Prominent Vendors

22. Key Vendor Analysis

22.1 Bristol-Myers Squibb Co.

22.1.1 Key Facts

22.1.2 Business Overview

22.1.3 Product Segmentation

22.1.4 Sales by Geography

22.1.5 Business Strategy

22.1.6 Key Information

22.1.7 SWOT Analysis

22.1.8 Strengths

22.1.9 Weaknesses

22.1.10 Opportunities

22.1.11 Threats

22.2 F. Hoffmann La Roche Ltd.

22.2.1 Key Facts

22.2.2 Business Overview

22.2.3 Business Segmentation

22.2.4 Business Segmentation by Revenue 2012 and 2013

22.2.5 Sales by Geography

22.2.6 Business Strategy

22.2.7 Key Information

22.2.8 SWOT Analysis

22.2.9 Strengths

22.2.10 Weaknesses

22.2.11 Opportunities

22.2.12 Threats

22.3 Merck & Co. Inc.

22.3.1 Key Facts

22.3.2 Business Overview

22.3.3 Business Segmentation by Revenue 2013

22.3.4 Business Segmentation by Revenue 2012 and 2013

22.3.5 Sales by Geography

22.3.6 Business Strategy

22.3.7 Key Developments

22.3.8 SWOT Analysis

22.3.9 Strengths

22.3.10 Weaknesses

22.3.11 Opportunities

22.3.12 Threats

22.4 Pfizer Inc.

22.4.1 Key Facts

22.4.2 Business Overview

22.4.3 Business Segmentation by Revenue 2013

22.4.4 Business Segmentation by Revenue 2012 and 2013

22.4.5 Sales by Geography

22.4.6 Business Strategy

22.4.7 Key Developments

22.4.8 SWOT Analysis

22.4.9 Strengths

22.4.10 Weaknesses

22.4.11 Opportunities

22.4.12 Threats

23. Other Reports in this Series



List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Global Hodgkin's Lymphoma Therapeutics Market 2013-2018 (US$ million)

Exhibit 3: NCI Lymphoma Research Portfolio 2013

Exhibit 4: Global Hodgkin's Lymphoma Therapeutics Market Segmentation by Drug Class

Exhibit 5: Global Hodgkin's Lymphoma Therapeutics Market by Geographical Segmentation 2013

Exhibit 6: Bristol-Myers Squibb Co.: Product Segmentation (Based on Therapeutic Areas)

Exhibit 7: Bristol-Myers Squibb Co.: Sales by Geography 2013

Exhibit 8: Business Segmentation of F. Hoffmann-La Roche Ltd. 2013

Exhibit 9: F. Hoffmann-La Roche Ltd: Business Segmentation by Revenue 2012 and 2013

Exhibit 10: F. Hoffmann-La Roche Ltd: Sales by Geography 2013 (Pharmaceuticals Division)

Exhibit 11: F. Hoffmann-La Roche Ltd: Sales by Geography 2013 (Diagnostics Division)

Exhibit 12: Merck & Co. Inc.: Business Segmentation by Revenue 2013

Exhibit 13: Merck & Co. Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)

Exhibit 14: Merck & Co. Inc.: Sales by Geography 2013

Exhibit 15: Pfizer Inc.: Business Segmentation by Revenue 2013

Exhibit 16: Pfizer Inc.: Business Segmentation by Revenue 2012 and 2013

Exhibit 17: Pfizer Inc.: Sales by Geography 2013


...
Publisher Name : Technavio

SIMILAR MARKET STUDIES

Please Select Format
Single User: US $ 2500
Site User: US $ 3500
Global User: US $ 10000

NEED MORE INFORMATION
Contact us
Call us +1-971-202-1575
--- or ---
help@bigmarketresearch.com
WHY BIG MARKET RESEARCH
With high quality and penned to perfection, Big Market Research is an exclusive online market to get best market research reports for your business needs and strategies. We recommend you to stop browsing as soon as you discover our website. This is because we firmly believe that once you reach here; all your business concerns will be addressed.

We have a huge collection of market research report from numerous filed which will provide you with all the necessary solution. We make sure that reports that we sell are true in context, have a quality that is unrivaled, fully integrated with equal spread of opinion. They will give you proper insights into different opportunities one may locate for their start-up pr expansion.

Let your qualms and concern be sidelined through our high end syndicated as well as customized reports.
Top